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GeOBJECTIVES The aim was to establish a contemporary scoring system to predict the outcome of chronic total occlusion
coronary angioplasty.
BACKGROUND Interventional treatment of chronic total coronary occlusions (CTOs) is a developing subspecialty.
Predictors of technical success or failure have been derived from datasets of modest size. A robust scoring tool could
facilitate case selection and inform decision making.
METHODS The study analyzed data from the EuroCTO registry. This prospective database was set up in 2008 and includes
>20,000 cases submitted by CTO expert operators (>50 cases/year). Derivation (n ¼ 14,882) and validation (n ¼ 5,745)
datasets were created to develop a risk score for predicting technical failure.
RESULTS There were 14,882 patients in the derivation dataset (with 2,356 [15.5%] failures) and 5,745 in the validation
dataset (with 703 [12.2%] failures). A total of 20.2% of cases were done retrogradely, and dissection re-entry was
performed in 9.3% of cases. We identified 6 predictors of technical failure, collectively forming the CASTLE score
(Coronary artery bypass graft history, Age ($70 years), Stump anatomy [blunt or invisible], Tortuosity degree [severe or
unseen], Length of occlusion [$20 mm], and Extent of calcification [severe]). When each parameter was assigned a value
of 1, technical failure was seen to increase from 8%with a CASTLE score of 0 to 1, to 35% with a score$4. The area under
the curve (AUC) was similar in both the derivation (AUC: 0.66) and validation (AUC: 0.68) datasets.
CONCLUSIONS The EuroCTO (CASTLE) score is derived from the largest database of CTO cases to date and offers a
useful tool for predicting procedural outcome. (J Am Coll Cardiol Intv 2019;12:335–42) © 2019 by the American College
of Cardiology Foundation.N 1936-8798/$36.00 https://doi.org/10.1016/j.jcin.2018.11.020
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336C hronic total occlusions (CTOs) arepresent in approximately one-fifthof patients undergoing coronary
angiography (1). Historically, these lesions
have often been managed either with medi-
cal therapy or coronary artery bypass graft
(CABG) in suitable candidates because of
their complexity and low interventional suc-
cess rates. Percutaneous coronary interven-tion (PCI) of CTOs has become more widely accepted
in the last decade, with increasing success rates
related to operator experience, guidewire technology,
and microcatheter sophistication (2). Despite these
improvements, procedural success rates remain
lower than those achieved with nonocclusive lesions
(3). A simple and accurate scoring tool to grade the
difficulty of cases would be valuable for appropriate
case selection and planning. Attempts have been
made to classify procedures according to their likeli-
hood of success based on patient, lesion, and proce-
dural features (4,5). However, these have been
derived from a relatively modest number of patients,
and consequently their predictive ability has not been
uniformly consistent (6). Additionally, some have
focused purely on the antegrade approach, to the
exclusion of retrograde possibilities (7). Using the Euro-
CTO registry, we analyzed the factors influencing tech-
nical success and derived and validated a simple model
to predict successful percutaneous treatment of CTOs.SEE PAGE 343METHODS
PATIENT POPULATION. The EuroCTO club is a
collaborative effort among high-volume CTO opera-
tors in Europe aimed at sharing experiences and
outcomes data. Since 2008, patient characteristics
and procedural data have been prospectively recor-
ded in a dedicated registry by individual members. In
this database, multiple variables are recorded forde Marne-la-vallée, Jossigny, France; rHelios Heart Center Kref
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received September 5, 2018; revised manuscript received Octobeevery patient regarding preprocedural demographic
and anatomical characteristics, procedural details,
and postprocedural outcomes. The data for this
analysis relate to patients in whom CTO recanaliza-
tion was attempted between 2008 and 2016 in 55
European centers. The aim of the analysis was to
develop a scoring system to predict the likelihood of
success of CTO PCI.
DEFINITIONS. Coronary CTOs were defined as oc-
clusions of >3 months duration with Thrombolysis In
Myocardial Infarction flow grade 0 intralesional cor-
onary flow (8). The length of coronary occlusions was
estimated from angiographic projections visually
with single- or dual-contrast injections. The degree of
calcification was visually estimated on fluoroscopy—
moderate calcification was considered to be present if
one-half of the total CTO segment had visible resi-
dues; extension of calcification to >50% of the
segment was considered to be severe. The CTO was
defined as straight if the pre-occlusive segment con-
tained a bend of <70. Moderate tortuosity was
defined as a segment containing either 2 bends >70
or 1 bend >90. A severely tortuous CTO vessel con-
tained either 2 or more pre-occlusive bends of >90 or
at least 1 bend of >120. The morphology of the vessel
stump was classified as tapered, blunt, or unseen
depending on its appearance on fluoroscopy. The
angiographic assessment of collateral connections
was made according to the Werner classification (9).
Opacification beyond the occlusion was classified into
either none, faint, or good. Good distal visibility was
defined as distal opacification comparable to the
proximal segment. Technical success was defined as a
residual stenosis of<10% at the end of the procedure
with TIMI flow grade 3 antegrade flow.
STATISTICAL METHODS. Pred ict ive model
deve lopment . The aim was to develop an accurate
predictive model from a large number of potential
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TABLE 1 Distribution of Patient Demographics, Medical History and Lesion
Characteristics in EuroCTO Cohort and Their Association With the Failure of Percutaneous




(n = 12,526, 84.2%)
Failure
(n ¼ 2,356, 15.8%)
Univariate Analyses
OR (95% CI) p Value
Previous CABG
No 12,489 10,678 (85.5) 1,811 (14.5) 1.00
Yes 1,942 1,516 (78.1) 426 (21.9) 1.66 (1.47–1.87) <0.001
Missing 451 332 (73.6) 119 (26.4) -
Age
<55 yrs 3,128 2,723 (87.1) 405 (12.9) 1.00 <0.001
55 yrs 2,269 1,925 (84.8) 344 (15.2) 1.20 (1.03–1.40)
60 yrs 2,517 2,118 (84.1) 399 (15.9) 1.27 (1.09–1.47)
65 yrs 2,307 1,937 (84.0) 370 (16.0) 1.28 (1.10–1.50)
70 yrs 2,262 1,860 (82.2) 402 (17.8) 1.45 (1.25–1.69)
75 yrs 1,468 1,201 (81.8) 267 (18.2) 1.49 (1.26–1.77)
80 yrs 907 744 (82.0) 163 (18.0) 1.47 (1.21–1.80)




9,411 8,224 (87.4) 1,187 (12.6) 1.00 <0.001
Moderate 3,355 2,810 (83.8) 545 (16.2) 1.34 (1.20–1.50)
Severe/
unseen
1,639 1,160 (70.8) 479 (29.2) 2.86 (2.53–3.23)
Missing 477 332 (69.6) 145 (30.4) -
Calcification
None/mild 8,327 7,330 (88.0) 997 (12.0) 1.00 <0.001
Moderate 4,062 3,425 (84.3) 637 (15.7) 1.37 (1.23–1.52)
Severe 1,973 1,394 (70.7) 579 (29.3) 3.05 (2.72–3.43)
Missing 520 377 (72.5) 143 (27.5) -
Stump
No 1,796 1,331 (74.1) 465 (25.9) 1.00
Blunt 5,809 4,772 (82.1) 1,037 (17.9) 2.00 (1.79–
2.22)
<0.001
Tapered 6,315 5,695 (90.2) 620 (9.8) 3.21 (2.81–3.67) <0.001
Missing 962 728 (75.7) 234 (24.3) -
Length of CTO
<20 mm 3,740 3,363 (89.9) 377 (10.1) 1.00 <0.001
20 mm 2,581 2,232 (86.5) 349 (13.5) 1.40 (1.19–1.63)
25 mm 1,580 1,358 (85.9) 222 (14.1) 1.46 (1.22–1.74)
30 mm 2,034 1,701 (83.6) 333 (16.4) 1.75 (1.49–2.05)
35 mm 4,053 3,300 (81.4) 753 (18.6) 2.04 (1.78–2.32)
Missing 894 572 (64.0) 322 (36.0) -
Values are n (%), unless otherwise indicated. The p values for the binary variable correspond to the Wald test,
otherwise to the trend test across groups.
CABG ¼ coronary artery bypass graft; CI ¼ confidence interval; CTO ¼ chronic total occlusion; OR ¼ odds ratio.
FIGURE 1 Risk Scores and Predicted Probabilities of Failure
of Percutaneous Coronary Intervention for Patients in the
EuroCTO Registry Derivation Dataset From 2008 to 2014
The graph represents the distribution of total risk scores of
14,882 patients with chronic total occlusion (CTO). The red
line shows the predicted procedural failures.
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337failure of CTO PCI. Potential predictive factors
strongly associated with the failure of the procedure
were selected from candidate variables with univari-
ate logistic regression analysis. These variables
included patient characteristics and medical history,
baseline measurements, and lesion characteristics.
Given the large number of patients and outcomes,
important independent clinical predictors were
identified using a stepwise approach with p < 0.01 as
the inclusion criterion. Using multiple imputed data
to account for missing values, patients’ demographic
data and medical history variables were first entered
into the logistic regression model. Baseline mea-
surements and lesion characteristics were then added
to the model and evaluated using the pre-set p value
of <0.01 for variable retention. In the final stage
variables initially excluded were sequentially re-
entered into the model and were re-assessed using
the pre-set inclusion criteria.
Mult ip le imputat ions . There were no missing
values for the outcome of the CTO procedure, but
data were missing for potential predictor variables
(<10% for each variable). To adjust for these missing
data, multiple imputation techniques with chained
equations were used, assuming missingness is at
random, with 20 imputations using all covariates
showing an association (p < 0.01) including the
outcome variable of technical success, smoking sta-
tus, gender, CTO location, and collateral circulation
(10). The variables included in the final model were
also imputed on the validation set using the same
multiple imputation techniques.Risk score ana lyses . The 2008 to 2014 cohort was
available initially to develop the risk score. The 2015
to 2016 cohort was used for the validation of the
model when these data became available and also to
help establish whether success rates had improved
over time. The coefficients in the final logistic model
can be used to develop a detailed risk score to predict
the probability of failure for each patient. However,
the aim of our analysis was to develop and present a
simplified, easy-to-use risk score for predicting fail-
ure. The multivariable predictive model was con-
verted into a simple risk score by allocating a 0 or 1
score for each variable in the model depending on the
value of that variable for each individual. For each
TABLE 2 Multivariable Logistic Regression Analysis for Failure of
Percutaneous Coronary Intervention by the EuroCTO CASTLE Model and the
Assignment of Risk Scores to the Risk Factors on the Imputed Derivation Set
EuroCTO CASTLE Model
Risk Factor OR (95% CI) p Value Log(OR) Robust Scoring
Previous CABG
No 1.00 0 0
Yes 1.42 (1.25–1.61) <0.0001* 0.35 1
Age
<55 yrs 1.00 <0.001 0 0
55 yrs 1.18 (1.01–1.38) 0.17 0
60 yrs 1.18 (1.01–1.37) 0.16 0
65 yrs 1.15 (0.98–1.35) 0.14 0
70 yrs 1.28 (1.09–1.49) 0.24 1
75 yrs 1.29 (1.08–1.54) 0.25 1
80 yrs 1.34 (1.09–1.66) 0.30 1
Tortuosity
Straight/slight 1.00 <0.001 0 0
Moderate 1.15 (1.02–1.28) 0.14 0
Severe/unseen 2.28 (2.00–2.60) 0.82 1
Calcification
None/mild 1.00 <0.001 0 0
Moderate 1.15 (1.03–1.28) 0.14 0
Severe 2.18 (1.92–2.47) 0.78 1
Stump
Tapered 1.00 <0.001 0 0
Blunt 1.64 (1.47–1.84) 0.50 1
No 2.74 (2.39–3.14) 1.01 1
Length of CTO
<20 mm 1.00 <0.001 0 0
20 mm 1.43 (1.23–1.67) 0.36 1
25 mm 1.49 (1.24–1.79) 0.40 1
30 mm 1.60 (1.36–1.89) 0.47 1
35 mm 1.78 (1.55–2.04) 0.58 1
Multiple imputation ¼ 20, observations ¼ 14,882; due to nonresponse the average relative
variance increase, was 0.048 and the largest fraction of missing information was 0.124. *The p
value corresponding to the Wald test otherwise to the trend test across groups.
CASTLE ¼ coronary artery bypass graft history, $70 yrs of age, stump anatomy (blunt or
invisible), tortuosity degree (severe or unseen), length of occlusion ($20 mm), and extent of
calcification (severe); other abbreviations as in Table 1.
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338risk factor the category with the lowest predicted risk
(i.e., the most beneficial group) was allocated a score
of 0 together with any categories with a coef-
ficient <0.20 in the model. A score of 1 was assigned
to categories in which the coefficient was $0.20 from
the multivariable logistic regression model (which
equates to an odds ratio of 1.22). The total risk score
for each individual in the cohort was then computed
by adding up the assigned scores for each factor. The
distribution of the patients’ total risk scores was split
into 4 risk groups for comparison of observed and
predicted probabilities of failure to ensure a reason-
able number of events in each risk group. On the
validation set, the same scoring systems were applied
as on the derivation set to classify the patients into
different levels of risk categories (Figure 1).
Model performance . The model performance was
inspected on the imputed data with the Hosmer-Lemeshow statistic comparing the observed and pre-
dicted probabilities of the patients in groups defined
by their predicted probabilities and with the area un-
der the curve (AUC) quantifying the ability of the
model to discriminate patients at high risk from pa-
tients at low risk. Overall model performance on the
validation set was assessed with the Brier score (11).
The regression coefficients from the derivation
dataset from the logistic model containing the 0 to 6
patient risk score were applied to compute the pre-
dicted risk of failure of PCI for patients in the vali-
dation set. To correct for the improvement in success
rates in the 2015 to 2016 cohort compared with the
2008 to 2014 cohort, an adjustment was made by
including the year of operation as a covariate into the
model. This allowed for an assessment of the validity
of the risk score while presenting better current es-
timates of actual predicted risks of failure. Risk scores
for the validation dataset were calculated in exactly
the same way as for the derivation dataset (i.e., by
allocating a score of 0 or 1 for each of the 6 variables
in the model and summing across variables).
Compar i son with J-CTO scor ing system.
We explored the discriminative capacity of the
commonly utilized J-CTO (Japanese Multicenter CTO
Registry) score (4) in our dataset. Score of 1 was first
allocated to J-CTO variables of previously failed
lesion, blunt or no stump, bending, severe calcifica-
tion, and occlusion length $20mm. The total risk
scores were then obtained on both the derivation and
validation sets. The discriminative performance of
J-CTO scoring system was assessed using receiver-
operating characteristic curves within both the deri-
vation and validation datasets.
RESULTS
PROCEDURAL CHARACTERISTICS. In 76.1% of cases,
PCI CTO was attempted for the first time while 3.7% of
cases had had more than 2 previous failed attempts.
Contralateral injection was used in one-half of the
cases. The majority of the cases were done using
either 6-F (42.8%) or 7-F guide catheters (44.5%).
Intravascular imaging with intravascular ultrasound
was performed in 7.4% of cases. The antegrade
approach was attempted in 86.1% of cases and was
successful in 82.7% of those cases. The single-wire
technique was commonly successful in recanaliza-
tion being used in over 75.7% of cases. This was fol-
lowed by the parallel wire technique (16.8% of
successful cases). Dissection re-entry techniques
were used in a minority of antegrade cases (2.1%). A
retrograde strategy was utilized in 20.2% in our
cohort, with this approach being used a priori in
FIGURE 2 Model Calibration in EuroCTO Registry Derivation
Dataset From 2008 to 2014 (n ¼ 14,882)
Comparison of the observed and predicted probabilities of
failure of percutaneous coronary intervention (PCI) across the
4 risk groups.
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33913.9%. Touching wire was most commonly used
(37.6%), followed by retrograde wire crossing
(30.8%), reverse controlled antegrade and retrograde
tracking and dissection (24.6%), and controlled
antegrade and retrograde tracking and dissection
(7.0%). The overall success rate of the retrograde
approach (including both upfront and bailout after
failed antegrade technique) was 67.3%.
DERIVATION OF THE EURO-CTO CASTLE RISK
ANALYSIS TOOL. Of 14,882 patients in the derivation
dataset (2008 to 2014), 2,356 (15.8%) had unsuccess-
ful CTO PCI. In the validation dataset (2015 to 2016),
there were 5,745 patients, with 703 (12.2%) who had
an unsuccessful CTO PCI. Demographic and clinical
variables were explored using the derivation dataset
for their association with an unsuccessful CTO pro-
cedure (Table 1, Online Tables 1 to 3).
The derivation dataset had 10,760 patients with no
missing values and 4,122 patients with at least 1TABLE 3 Observed and Predicted Risks on the
Derivation Dataset
Risk Scores Procedures Failures Mean Predicted Risk (%)
0 1,129 68 5.8
1 3,959 347 9.3
2 5,530 797 14.5
3 2,936 671 22.1
4 1,056 345 32.3
5 238 110 44.7
6 34 18 56.5
Total 14,882 2,356 15.8missing value for the predictor variables, which were
imputed as described previously. On multivariable
analysis of 21 variables associated on univariable
analysis, 6 were identified on the imputed dataset as
strong independent predictors of failure of CTO PCI,
collectively forming the CASTLE (CABG, age, stump
anatomy, tortuosity, length of CTO, and extent of
calcification) model. The estimated odds ratios of the
association between these variables and the failure of
PCI are shown in Table 2. Previous CABG, blunt or no
stump, severe tortuosity, high level of calcification,
occlusion >20 mm, and age above 70 years were all
independently associated with an increased risk of
failure of the intervention.
To develop an easy to use scoring system able to
identify patients at highest risk of CTO PCI failure, a
robust risk score was developed, allocating 0 or 1 for
each variable depending on which category a patient
was in (Table 2, Online Table 4). The risk score was
calculated by the simple addition across all variables.
To compare the observed and predicted risk for the
simple risk score, the total scores were grouped into 4
categories (Figure 2 and Table 3). The total risk scores
and risk categories showed good separation of the
failure rates across the risk groups. There were 18
unsuccessful PCI procedures in 34 patients with total
risk score of 6 (52.9%) compared with 68 unsuccessful
procedures in 1,129 patients (6.0%) with risk score of
0, an 8-fold increase in risk. Overall, a good agree-
ment was found between the observed and predicted
risks within each group (Table 3, Figure 2), demon-
strating good model calibration.
Using the CASTLE model with the identified pre-
dictive factors (Table 1) Hosmer-Lemeshow goodness-
of-fit test revealed good agreement between the
predicted and observed probabilities of failure of PCI
(chi-square test value with degrees of freedom of 13 ¼
18.79; p ¼ 0.10 for any imputed dataset), demon-
strating that the model was well calibrated. The
discriminating ability of the CASTLE model based on
the robust scoring defined by the AUC of the total risk
scores (AUC: 0.66) was reasonable to distinguish pa-
tients at low and high risk.
VALIDATION OF THE EURO-CTO CASTLE RISK
ANALYSIS TOOL. The distribution of the identified
predictive variables by the outcome of the procedure
on the validation Euro-CTO dataset from years 2015
and 2016 is shown in Online Table 5. The validation
dataset had 5,258 patients with no missing values and
487 patients with at least 1 missing value for the
predictor. The distribution of the total risk scores of
patients in the imputed validation set (Figure 3A) was
very similar to that on the derivation set (Figure 1).
Although the model seems to overestimate the
FIGURE 3 Risk Scores and Calibration of the CASTLE Model in the EuroCTO Registry Validation Dataset From 2015 and 2016
(A) Distribution of the risk scores of 5,745 patients with chronic total occlusion. (B) Comparison of the observed and predicted probabilities of
failure of percutaneous coronary intervention computed by the EuroCTO CASTLE (coronary artery bypass graft history, age, stump anatomy,
tortuosity degree, length of occlusion, and extent of calcification) model across the 4 risk groups.
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340likelihood of failure of PCI to some extent (Figure 3B,
Online Tables 6 and 7), this can largely be explained
by the improved success rate over time. The overall
rate of the observed failure of PCI on the derivation
set (15.8%, 2,356 of 14,482) was higher by 3.5% than
that on the validation set (12.2%, 703 of 5,745). A
decreasing trend year on year in the observed annual
failure rates from years 2008 to 2016 was also
revealed (p < 0.001) (Figure 4). Adjusting the CASTLE
model for year of operation indeed proved that this
improvement in the success of PCI helps to explain
small discrepancies between the observed andFIGURE 4 Annual Failure Rates of PCI of CTO From
2008 to 2016
The decreasing trend year on year in the observed annual failure
rates was statistically evaluated with trend test (p < 0.001).
Abbreviations as in Figures 1 and 2.predicted failure rates computed by the CASTLE al-
gorithm on the validation set (Figure 5, Online
Table 8). The overall model performance on the
validation set quantified by the Brier score (0.103 and
0.102 without and with the adjustment of the CASTLE
model for year of operation, respectively) was
reasonable. The concordance probability measured by
the AUC was actually higher on the validation set
(AUC for both unadjusted and adjusted models: 0.68)
when compared with the derivation set (AUC: 0.66).
COMPARISON WITH J-CTO SCORE. The AUC of J-
CTO scoring tool was 0.63 and 0.64 within the
training and validation sets, respectively. In com-
parison, our AUC showed a higher discriminatory
capacity for both datasets (AUC for the derivation set:
0.66; AUC for the validation set: 0.68).
DISCUSSION
We present a simple scoring system to predict tech-
nical success when performing CTO PCI. Despite
technical advances, CTO PCI remains one of the most
difficult areas of interventional cardiology and the
one most likely to fail. Therefore, being able to pre-
dict in advance the likelihood of success will help
cardiologists choose wisely, in a number of important
ways. First, it will help guide interventionalists dur-
ing their learning phase as CTO operators in terms of
case selection. Second, it will aid Heart Team dis-
cussions regarding the likelihood of complete revas-
cularization with PCI or CABG. Third, it will aid
comprehensive informed consent for patients
regarding the likelihood of CTO PCI success.
FIGURE 5 Comparison of the Observed Risk Scores and the
Adjusted Predicted Risk Scores on the EuroCTO Registry
Validation Dataset From 2015 and 2016 (n ¼ 5,745)
The CASTLE (coronary artery bypass graft history, age, stump
anatomy, tortuosity degree, length of occlusion, and extent of
calcification) model was adjusted for the effect of time on
failure rate before computing the predicted failure rate of
percutaneous coronary intervention (PCI).
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341A number of scoring systems have been developed
over the years to predict successful PCI. Morino et al.
(4) published the J-CTO score in 2011, derived from
400 CTO cases. This study identified 5 characteristics
associated with failure to pass an antegrade guide-
wire across the occlusion within 30 min (4). The
characteristics included a previous failed attempt and
did not include previous CABG (widely recognized to
be an adverse feature). While procedural failure has
been shown to be associated with higher lesion scores
in some studies, this relationship has not been
observed consistently (6).
Alessandrino et al. (7) published the single-center
CL-score that identified independent predictors of
procedural failure in patients undergoing CTO-PCI for
the first time. Two clinical variables (history of CABG
and previous myocardial infarction) and 4 lesion-
specific characteristics (blunt stump, lesion calcifica-
tion, non–left anterior descending artery CTO, and
lesion length >20 mm) were found to be associated
with an unsuccessful procedure.
The PROGRESS CTO (Prospective Global Registry
for the Study of Chronic Total Occlusion Intervention)
complications score developed by Christopoulos et al.
(12) estimated the likelihood of success in CTO treated
using a hybrid approach. Four lesion characteristics—
proximal cap ambiguity, moderate-to-severe tortu-
osity, circumflex artery CTO, and absence of retro-
grade collaterals—were found to determine technical
success.Maeremans et al. (13) recently published the
RECHARGE Registry (Registry of CrossBoss and
Hybrid Procedures in France, the Netherlands,
Belgium and United Kingdom). Six factors associated
with technical failure were identified: a blunt stump,
lesion calcification, in-lesion tortuosity $45, lesion
length >20 mm, a diseased distal landing zone, and
previous bypass graft on the CTO vessel. However,
this score was derived from 880 patients undergoing
a particular approach to CTO treatment using the
CrossBoss or Hybrid techniques, used relatively rarely
in the EuroCTO database. However, it is reassuring to
see that some negative predictors remain consistent.
The strength of the EuroCTO CASTLE score rests on
the large and varied volume of patients fromwhich it is
derived and validated. Some of the prior scoring sys-
tems were from a single institution, based on the
antegrade technique alone or on relatively modest
numbers of patients. This study uses patient numbers
an order of magnitude greater, with cases undertaken
by a large number of different operators across Europe
and should therefore reflect more accurately global
practice and offer greater contemporary relevance.
Previous scores have provided valuable insight into
the predictors of failure. However, some of these are
no longer contemporary, and our study demonstrates
the importance of adjusting for improved success rates
over time in predicting actual failure rates. Despite
this change over time, the score performs well both in
identifying predictors of procedural failure and
demonstrating their persisting relevance.
Our scoring system has a greater discriminative ca-
pacity compared with the widely used J-CTO score.
The EuroCTO CASTLE score incorporates 4 factors that
are included in the other 2 main general scoring sys-
tems—stump anatomy (J-CTO score); tortuosity (J-CTO
[in-lesion] and PROGRESS scores), length of occlusion
(J-CTO and PROGRESS scores), and extent of calcifi-
cation (J-CTO). Importantly, however, it also includes
2 additional variables—previous CABG and age, both of
which are objective and not open to operator inter-
pretation. This enhances the functional integrity of
the score. It is also noteworthy that the incidence of
previous CABG was lower at 6% to 9% in the previous
main scoring systems but was 13% in the EuroCTO
registry. This relatively higher prevalence helps justify
why previous CABG merits consideration as an
important variable. Although our score is broadly
similar to published ones, our study confirms the
importance of previously identified predictors of CTO
PCI success using contemporary data from amultitude
of operators. To facilitate usage and uptake, we
deliberately simplified the scoring system using a
point-based approach. We will also be creating a more
PERSPECTIVES
WHAT IS KNOWN? Interventional treatment of
CTOs is a developing subspecialty. Demographic and
anatomical criteria that can predict outcome have
been derived from relatively modest sample sizes and
not been subject to extensive contemporary data
analysis.
WHAT IS NEW? We examined data from the Euro-
CTO Registry of 20,000 prospectively entered cases
from dedicated CTO operators and created a simple
integer scoring system to predict technical outcome.
The following factors were found to be of greatest
importance—coronary artery bypass graft history, age,
stump anatomy, tortuosity degree, length of occlu-
sion, and extent of calcification. Technical failure rates
range from 8% (CASTLE score 0 to 1) to 35% (CASTLE
score $4).
WHAT IS NEXT? The predictive ability of our model
needs to be validated in future studies.
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342precise model using the original coefficients of the
model, which will be available in App form.
STUDY LIMITATIONS. Our analysis was performed on
registry data in the absence of independent verifica-
tion by core laboratory. Lack of external validation is
a limiting factor in our analysis. In addition, while
procedural outcome was obtained in all cases, data
collection on variables was incomplete. However, the
amount of missing data did not exceed 10% for any
variable. Angiographic data were obtained by visual
assessment rather than by quantitative coronary
analysis. Thus, we cannot eliminate operator-related
bias. Data were collected from high-volume centers
with highly skilled operators at CTO PCI. Our model
may not apply to centers where operator experience
is lower. The failure rate for CTO PCI fell gradually
during the course of the study, and therefore the
predictive failure rates are marginally higher than
those seen in the final year of the Registry.
CONCLUSIONS
The EuroCTO (CASTLE) prediction score is a
multicenter-derived scoring system to predict tech-
nical failure in the percutaneous treatment of CTO.
Previous CABG, over 70 years of age, a blunt stump,
severe tortuosity, length of the occlusion, and extent
of calcification were strongly associated with unsuc-
cessful CTO-PCI.ADDRESS FOR CORRESPONDENCE: Dr. David
Hildick-Smith, Sussex Cardiac Centre, Eastern
Road, Brighton, United Kingdom. E-mail: david.
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